- Home
- OGE vs EXAS Comparison
OGE vs EXAS Comparison
Compare OGE & EXAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OGE
- EXAS
- Stock Information
- Founded
- OGE 1902
- EXAS 1995
- Country
- OGE United States
- EXAS United States
- Employees
- OGE N/A
- EXAS N/A
- Industry
- OGE Electric Utilities: Central
- EXAS Medical Specialities
- Sector
- OGE Utilities
- EXAS Health Care
- Exchange
- OGE Nasdaq
- EXAS Nasdaq
- Market Cap
- OGE 9.2B
- EXAS 10.2B
- IPO Year
- OGE N/A
- EXAS N/A
- Fundamental
- Price
- OGE $43.99
- EXAS $52.93
- Analyst Decision
- OGE Strong Buy
- EXAS Strong Buy
- Analyst Count
- OGE 5
- EXAS 22
- Target Price
- OGE $46.80
- EXAS $67.38
- AVG Volume (30 Days)
- OGE 914.5K
- EXAS 2.8M
- Earning Date
- OGE 11-04-2025
- EXAS 11-04-2025
- Dividend Yield
- OGE 3.81%
- EXAS N/A
- EPS Growth
- OGE 19.03
- EXAS N/A
- EPS
- OGE 2.43
- EXAS N/A
- Revenue
- OGE $3,215,200,000.00
- EXAS $2,939,949,000.00
- Revenue This Year
- OGE $7.36
- EXAS $16.68
- Revenue Next Year
- OGE $4.43
- EXAS $12.08
- P/E Ratio
- OGE $18.21
- EXAS N/A
- Revenue Growth
- OGE 16.01
- EXAS 12.55
- 52 Week Low
- OGE $39.10
- EXAS $38.81
- 52 Week High
- OGE $46.91
- EXAS $72.83
- Technical
- Relative Strength Index (RSI)
- OGE 43.32
- EXAS 58.53
- Support Level
- OGE $43.60
- EXAS $52.11
- Resistance Level
- OGE $44.67
- EXAS $56.52
- Average True Range (ATR)
- OGE 0.56
- EXAS 1.66
- MACD
- OGE -0.03
- EXAS 0.13
- Stochastic Oscillator
- OGE 40.74
- EXAS 64.29
About OGE OGE Energy Corp
OGE Energy is a holding company for Oklahoma Gas & Electric, a regulated utility with electricity generation, transmission, and distribution to 900,000 customers in Oklahoma and western Arkansas. In December 2021, OGE divested its 25.5% stake in Enable Midstream Partners, an oil and gas services company it created in 2013 through a unit exchange merger with Energy Transfer. OGE sold its 95.4 million limited partner units of Energy Transfer throughout 2022. OGE sold its retail gas business in 1928 and no longer has any gas operations.
About EXAS Exact Sciences Corporation
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.